A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: A multicentre, prospective clinical trial

BACKGROUND: Topical azelaic acid (AzA) is a common treatment for mild/moderate inflammatory rosacea. AIMS: To assess the efficacy and tolerability of a novel formulation cream containing 15% AzA (anti‐inflammatory/anti‐oxidant/anti‐microbial agent) combined with 1% dihydroavenanthramide D (anti‐infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Dall’Oglio, Federica, Tedeschi, Aurora, Lacarrubba, Francesco, Fabbrocini, Gabriella, Skroza, Nevena, Chiodini, Paolo, Micali, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252084/
https://www.ncbi.nlm.nih.gov/pubmed/33934475
http://dx.doi.org/10.1111/jocd.14098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252084/
https://www.ncbi.nlm.nih.gov/pubmed/33934475
http://dx.doi.org/10.1111/jocd.14098

Ejemplares similares